This must-attend event features a cutting-edge agenda with insights from top government agencies, leading scientists, and ...
13h
News Medical on MSNIgE antibodies show promise in targeting HER2 cancers resistant to other therapiesAntibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results